Hot Products

Vinorelbine
Catalog No: CFN90401

Vinorelbine is a semi-synthetic Vinca alkaloid which is currently used in treatment of different cancer types mainly advanced breast cancer (ABC) and advanced/metastatic non-small cell lung cancer (NSCLC). Vinorelbine-loaded SSM can be developed as a new, safe, stable, and effective nanomedicine for the treatment of breast and lung cancers.

Viscidulin I
Catalog No: CFN97489

Reference standards.

Viscidulin II
Catalog No: CFN92214

Viscidulin II can be potential therapeutic agents against P. acnes-induced skin inflammation, it can significantly suppress P. acnes-induced IL-8 and IL-1β production in THP-1 cells, concomitant intradermal injection of viscidulin II with P. acnes can effectively attenuate P. acnes-induced ear swelling, and decrease the production of IL-6 and tumor necrosis factor-α in ear homogenates.

Viscidulin III
Catalog No: CFN97488

Viscidulin III (17.4 microM), wogonin (17.4 microM) and luteolin (18.4 microM) were more effective than baicalein (23.0 microM) which reportedly inhibits the proliferation of some cancer cell lines.

Viscosalactone B
Catalog No: CFN92968

Viscosalactone B shows antiproliferative activity on NCI-H460 (Lung), HCT-116 (Colon), SF-268 (Central Nervous System; CNS and MCF-7 (Breast) human tumor cell lines. It also shows selective COX-2 enzyme inhibition.

Viscumneoside III
Catalog No: CFN89421

Viscumneoside III demonstrates high tyrosinase inhibition, it can be utilized in skin whitening cosmetics.

Visnadine
Catalog No: CFN91656

Visnagin
Catalog No: CFN97314

Visnagin has acute hypotensive, anti-inflammatory, and neuroprotective effects, it protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase. Visnagin can relax aortae previously contracted by noradrenaline, and weakly inhibit the hydrolytic activity of the cyclic nucleotide phosphodiesterase (PDE) isozymes (PDE5, PDE4, PDE3, cyclic GMP activated PDE2 and PDE1).

Vitamin D3
Catalog No: CFN90027

Vitamin D3 is a form of vitamin D, binds and activates a H305F/H397Y mutant vitamin D receptor (VDR) with EC50 of 300 nM. Supplemental calcium and Vitamin D3 may increase TGFβ1 expression and shift TGFα expression downward from the differentiation to the proliferation zone in the crypts in the normal-appearing colorectal mucosa of sporadic colorectal adenoma patients.

Vitamin K1
Catalog No: CFN90050

Vitamin K1, a fat-soluble, naturally occurring vitamin required for blood coagulation and bone and vascular metabolism. Vitamin K1 has anticoagulation activity, it may attenuate liver fibrosis by inhibiting hepatic stellate cell activation in bile duct-ligated rats; it inhibits diabetic-cataract by modulating lens Ca2+ homeostasis and its hypoglycemic effect through its direct action on the pancreas.Vitamin K1 may substantially contribute to reducing postmenopausal bone loss at the site of the femoral neck.